Therapeutic Advances in Endocrinology and Metabolism: 2023, vol: 14, issue:
1)- Anas Ababneh, Kathleen Finlayson, Helen Edwards, Jaap J van Netten, Peter A Lazzarini. Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188221142457
2)- Rosaria Maria Pipitone, Carlo Ciccioli, Giuseppe Infantino, Claudia La Mantia, Stefanie Parisi, Adele Tulone, Grazia Pennisi, Stefania Grimaudo, Salvatore Petta. MAFLD: a multisystem disease.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188221145549
3)- Laure Boutsen, Elise Costenoble, Olivier Pollé, Kezban Erdem, Céline Bugli, Philippe A Lysy. Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188221145550
4)- Shreya C Pal, Nahum Méndez-Sánchez. Screening for MAFLD: who, when and how?Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188221145650
5)- Jun Tang. Immune checkpoint inhibitors: friend or foe for osteoporosis.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231157194
6)- Brian M Schmidt, Laura Shin. Tackling diabetic foot: limb salvage during the COVID-19 pandemic.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231157203
7)- Rudolf Hoermann, Mark J Pekker, John E M Midgley, Johannes W Dietrich. The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic-pituitary-thyroid axis.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231158163
8)- Robert Hegarty, Eirini Kyrana, Emer Fitzpatrick, Anil Dhawan. Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231160388
9)- Blanca Norero, Jean-François Dufour. Should we undertake surveillance for HCC in patients with MAFLD?Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231160389
11)- Juanita K Hodax, Sara DiVall. Gender-affirming endocrine care for youth with a nonbinary gender identity.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231160405
12)- Catherine Gooday, Wendy Hardeman, Fiona Poland, Jim Woodburn, Ketan Dhatariya. Controversies in the management of active Charcot neuroarthropathy.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231160406
13)- Matthew J Johnson, Suganthi Kandasamy, Katherine M Raspovic, Kshitij Manchanda, George Tye Liu, Michael D VanPelt, Lawrence A Lavery, Dane K Wukich. Fractures and dislocations of the foot and ankle in people with diabetes: a literature review.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231163794
14)- Fotios Barkas, Georgia Anastasiou, George Liamis, Haralampos Milionis. A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231163806
15)- Ploutarchos Tzoulis. Therapy for SIAD: what does the future hold?Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231166493
16)- Sean J Iwamoto, Justine Defreyne, Christodoulos Kaoutzanis, Robert D Davies, Kerrie L Moreau, Micol S Rothman. Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231166494
17)- Baodi Xing, Jie Yu, Huabing Zhang, Yuxiu Li. RANKL inhibition: a new target of treating diabetes mellitus?Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231170754
18)- Kevin K W Kuan, Sean Omoseni, Javier A Tello. Comparing ART outcomes in women with endometriosis after GnRH agonist GnRH antagonist ovarian stimulation: a systematic review.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231173325
19)- Ploutarchos Tzoulis, Gregory Kaltsas, Stephanie E Baldeweg, Pierre-Marc Bouloux, Ashley B Grossman. Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD).Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231173327
20)- Anand V Kulkarni, Shiv Kumar Sarin. The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231178370
22)- Ethan Moreland, Ada S Cheung, Danielle Hiam, Brendan J Nolan, Shanie Landen, Macsue Jacques, Nir Eynon, Patrice Jones. Implications of gender-affirming endocrine care for sports participation.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231178373
23)- Julie Chen. Is there a causal relationship between hypothyroidism and hyponatremia?Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231180983
24)- Khary Edwards, Aleksandra Uruska, Anna Duda-Sobczak, Dorota Zozulinska-Ziolkiewicz, Ildiko Lingvay. Patient-perceived benefits and risks of off-label use of SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabetes: a structured qualitative assessment.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231180987
25)- Nicole Kattner. Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231185958
26)- Xin Shi, Lingling Li, Zhiyao Liu, Fangqi Wang, Hailiang Huang. Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231187493
27)- Lavanya Athithan, Gaurav S Gulsin, Joseph Henson, Loai Althagafi, Emma Redman, Stavroula Argyridou, Kelly S Parke, Jian Yeo, Thomas Yates, Kamlesh Khunti, Melanie J Davies, Gerry P McCann, Emer M Brady. Response to a low-energy meal replacement plan on glycometabolic profile and reverse cardiac remodelling in type 2 diabetes: a comparison between South Asians and White Europeans.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231193231
28)- Ploutarchos Tzoulis, Maria P Yavropoulou. Association of hyponatremia with bone mineral density and fractures: a narrative review.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231197921
29)- Shiyi Sun, Lihong Chen, Dawei Chen, Yan Li, Guanjian Liu, Lin Ma, Jun Li, Fangwei Cao, Xingwu Ran. Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231198620
30)- Jing Zhu, Yier Zhou, Bihui Jin, Jing Shu. Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231199359
31)- Li-Hsin Chang, Chia-Huei Chu, Chin-Chou Huang, Liang-Yu Lin. Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231207345
32)- Steven Rella, Joseph Onyiah, Chelsea Baker, Vatsala Singh, Andrew Her, Neda Rasouli. Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide placebo on intestinal barrier function in type 2 diabetes mellitus.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231207348
33)- Trupti Nagendra Prasad, Sanjay Kumar Bhadada, Veenu Singla, Neelam Aggarwal, Sant Ram, Uttam Chand Saini, Ashok Kumar, Rimesh Pal. Efficacy of zoledronate, denosumab or teriparatide in postmenopausal women with type 2 diabetes mellitus at high risk of fragility fractures: protocol of an open, blinded endpoint randomized controlled pilot trial.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231207516
34)- Andreas Kiriakopoulos, Periklis Giannakis, Evangelos Menenakos. Pheochromocytoma: a changing perspective and current concepts.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231207544
35)- Tamer Mohamed Elsherbiny. Hypovitaminosis D masking hypercalcemia in primary hyperparathyroidism: case report.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231213208
36)- Sharon Giveon, Galia Zacay, Iris Vered, A Joseph Foldes, Liana Tripto-Shkolnik. Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231213639
37)- Madhusmita Rout, Gurpreet S Wander, Sarju Ralhan, Jai Rup Singh, Christopher E Aston, Piers R Blackett, Steven Chernausek, Dharambir K Sanghera. Assessing the prediction of type 2 diabetes risk using polygenic and clinical risk scores in South Asian study populations.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231220120
38)- Nur Berna Celik, Dicle Canoruc Emet, Merve Canturk, Z Alev Ozon, E Nazli Gonc. Dual-basal-insulin regimen for the management of dawn phenomenon in children with type 1 diabetes: a retrospective cohort study.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231220130
39)- Lan Wei, Jingjing Gao, Liangzhi Wang, Qianru Tao, Chao Tu. Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications.Therapeutic advances in endocrinology and metabolism. 2023, 14: 20420188231220134